XML 54 R43.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT INFORMATION (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Total revenues $ 70,588 $ 26,840 $ 111,603 $ 105,511
Cost of revenues (excluding amortization and depreciation) 22,838 7,247 36,396 16,403
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 225,774 169,410 632,062 275,077
Selling, general and administrative and Salaries and Benefits expense (excluding stock based compensation  and amortization expense) 687,012 594,161 1,309,958 1,239,882
Amortization 5,125 3,793 9,912 6,454
Stock based compensation 572,100 308,283 1,208,945 469,632
Professional fees 178,597 240,967 546,413 468,796
Interest income, net (4,690) (66) (5,793) (370)
Equity in net (income) loss from equity method investees 1,291 1,048 (4,492)
Other income (35,181) (13,753) (58,014) (40,221)
Segment net loss (1,580,987) (1,284,493) (3,569,324) (2,325,650)
Reconciliation of net loss        
Adjustments and reconciling items
Consolidated net loss (1,580,987) (1,284,493) (3,569,324) (2,325,650)
Clinical trials [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 122,176 9,587 201,578 10,825
Halo Project [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 90,534 118,299 388,571 221,776
Desktop project [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 11,700 41,524 35,413 41,523
Other research and development [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): $ 1,364 $ 6,500 $ 953